Suvretta Capital Management »

Replimune Group shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $350k 36k 9.72

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Arcutis Biotherapeutics (ARQT)
Ark Etf Tr Genomic Rev Etf Put Option (ARKG)
Benitec Biopharma Com New (BNTC)
Legend Biotech Corp Sponsored Ads (LEGN)
Eyepoint Com New (EYPT)
Arcus Biosciences Incorporated (RCUS)
Immatics SHS (IMTX)
Biohaven (BHVN)
Meta Platforms Cl A (META)
Apellis Pharmaceuticals (APLS)
NVIDIA Corporation (NVDA)
Coca-Cola Company (KO)
Ge Aerospace Com New (GE)
Amazon (AMZN)

View all positions for Suvretta Capital Management

Top funds holding Replimune Group

Baker Bros. Advisors
Rtw Investments
BlackRock
Vanguard Group
State Street Corporation
Fcpm Iii Services B.v.
Balyasny Asset Management
Erste Asset Management GmbH
Susquehanna International
Millennium Management
Geode Capital Management
Commodore Capital
Rosalind Advisors
Toronto-Dominion Bank
FMR

View all funds holding Replimune Group